Log in
Enquire now
‌

US Patent 11166996 Anellovirus compositions and methods of use

Patent 11166996 was granted and assigned to Flagship Pioneering on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Flagship Pioneering
Flagship Pioneering
Current Assignee
Flagship Pioneering
Flagship Pioneering
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11166996
Patent Inventor Names
Simon Delagrave0
Kevin James Lebo0
Nathan Lawrence Yozwiak0
Ryan D. Tedstone0
Avak Kahvejian0
Dhananjay Maniklal Nawandar0
Erica Gabrielle Weinstein0
Fernando Martin Diaz0
...
Date of Patent
November 9, 2021
Patent Application Number
20190621
Date Filed
June 21, 2019
Patent Primary Examiner
‌
Ileana Popa
Patent abstract

This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11166996 Anellovirus compositions and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.